Markets
Keith Gill, known on Reddit under the pseudonym...
Keith Gill (Photo illustration by Pavlo Gonchar / Getty Images)

Roaring Kitty’s $240 million problem

The account is a whale in a position in which there are few natural buyers.

6/3/24 3:04PM

What do you do when your like for a stock exceeds the money you have to spend on it?

That’s the position DeepFuckingValue, aka Keith Gill, aka Roaring Kitty may find themselves in right now.

Don’t get me wrong: this is an amazing problem to have.

A screenshot posted to the Superstonk subreddit on Sunday evening by the account associated with Keith Gill revealed a stock and options position in GameStop of roughly $180 million, along with about $30 million in cash. In other words, $210 million more than most of us.

Boilerplate disclosure: We don’t know if the positioning in this screenshot is accurate. But let’s proceed as if it is, for fun.

Those 120,000 call options give their holder the ability to purchase 12 million shares of GameStop at a strike price of $20 (C20s). The issue is…exercising your right to do so would cost $240 million. And, as of 2:00pm ET, the value of the stock position and cash only amounts to about $185 million.

Another problem with those options: none of DeepFuckingValue’s most zealous followers would want to take them off his hands.

They’re no longer YOLO bets; the options are very solidly in-the-money (because the stock trades above $20). Options that are out-of-the-money have far more potential for explosive upside moves than in-the-money options as the underlying stock price rises. For example, the in-the-money C20s that expire on June 21 rose as much as 285% today; the out-of-the-money C50s rose as much as 490%. The volume stats back this up: As of ~2:10 pm ET, about 7,500 of the C20s changed hands on Monday, compared to 9,000 for the C30s and 16,700 for the C40s.

The account is a whale in a position in which there are few natural buyers — it holds about 83% of the open interest in aggregate heading into Monday’s session.

If no activity happened between now and the June 21 expiry, there is a risk that the brokerage (E-Trade, by the looks of it) would be forced to step in and sell off some of the account’s options (to the extent market makers are willing to buy them). If buyers cannot be found, this may result in the money-good options expiring worthless if there isn’t enough cash and margin available to exercise them.

Per E-Trade (emphasis added)::

E*TRADE reserves the right to liquidate or cover expiring option positions which would result in undue risk and/or margin deficit related to exercise or assignment.

Accounts with insufficient equity on hand prior to exercise or assignment are subject to unwarranted risk of adverse price change in the underlying security upon delivery.  To protect against the excessive risk of an adverse movement in the underlying security, E*TRADE may intervene to mitigate the risk on your behalf.  Such intervention may include closing out existing positions, buying, or selling stock against expected exercises or assignments, or entering “Do Not Exercise” instructions for positions expiring in-the-money.  Any losses incurred from actions taken to mitigate risk are the sole responsibility of the account holder.

Obviously, if you’re option-rich and cash-poor (relatively speaking), this is the kind of outcome you’d like to avoid. But how?

Well, one could simply look to sell the options over the next few weeks as they approach expiry. In theory, this sounds easy. In practice, again, this looks to be an account with an extremely dominant position in one particular option and a seeming inability to exercise said option contracts. So, that road might be a bumpy one — but still, one almost certainly worth pursuing. We’ll be checking on the open interest in that contract tomorrow morning to see whether that process is starting to play out.

But another deliciously ironic way of navigating this conundrum was suggested by Steve Sosnick, chief strategist at Interactive Brokers: DeepFuckingValue would need to sell shares of GameStop short.

“Whoever holds this would be nuts if they’re not monetizing that position,” he said. “Standard operating procedure when looking at a profit this big involving options is to either sell the options, or, if they are deeply in-the-money, to sell the stock short.”

The sequencing would go a little something like this: 

  1. From a starting point of 5 million shares and 120,000 options contracts, sell all of those shares (very possible) and what you can of the options (not that much) during the surge this morning. There is much, much more liquidity in the stock than the C20s.

  2. Then, go beyond that by selling shares of GameStop short — roughly 10 million shares’ worth — to neutralize the long position embedded in your in-the-money options. That locks in the profit made this morning.

  3. As you continue to monetize the options position in the days ahead, you can correspondingly lighten up on the short bet. Then, at the time of expiry, if the shares are still above $20, you can exercise the options and have that stock cancel out your short sales.

The position could be structured in a number of different ways to still leave an overall bullish tilt on GameStop, rather than fully neutralizing the exposure. 

Who really knows what’s happening here. But it’s hilarious to imagine that, in acting in their own self-interest, DeepFuckingValue might be well-served by doing what catalyzed legions of retail investors to get long in the first place: becoming a whale shorting shares of GameStop. Even if it’s more of a trading accounting gimmick than him no longer "liking the stock."

More Markets

See all Markets
markets

Why Apple usually falls on a new iPhone launch

You can only shock the world so many times, and a thinner phone with a better camera isn’t always going to cut it.

That, in short, is why Apple has tended to go down on days when it’s introduced a new iPhone to the world, as this great chart from Bespoke Investment Group shows:

Bespoke iPhone announcement Apple performance
Source: Bespoke Investment Group

On average, the tech giant falls 0.4% on the release date and is negative more than 70% of the time, perhaps a useful tidbit on this, the day of the iPhone 17 launch.

One more thing....

A potentially complicating factor to the aforementioned data is that Apple has often done quite well in the six months leading up to a new iPhone announcement, roughly 5 percentage points better than its typical six-month return, as shown above. That’s not the case this time, with Apple shares up about 5% over the past six months compared to a typical near 20% advance in the prelude to a new iPhone drop.

So it’s not like expectations about how big of a catalyst this can be for the company are sky-high and due for a sharp retrenchment, especially given Apple’s relatively lackluster progress in developing AI capabilities relative to its megacap tech peers. But a seemingly low bar to clear hasn’t necessarily been a boon for the company on the big day, either.

In any event, staring too closely at the minutiae of all this may be missing the forest for the trees.

“While this info may be helpful to traders, we doubt its something that long-term shareholders are too worried about given the huge compounding returns the stock has provided during the iPhone era,” Bespoke wrote.

markets

Planet Labs slips after big post-earnings gain

Smallish midcap satellite imagery and data company Planet Labs is giving back a chunk of the nearly 50% gain it racked up after posting earnings early Monday.

No tears, though: the shares, which seem to have a fairly robust retail following, are still up roughly 340% over the past 12 months.

markets

CoreWeave soars as Microsoft’s deal with Nebius shows unrelenting demand for AI compute

CoreWeave is soaring as Microsoft’s $17.4 billion deal with Nebius shows the immense value and continued demand for all parts of the AI data center ecosystem.

One additional reason for CoreWeave’s jump may be that its pending acquisition of AI data center infrastructure company Core Scientific looks like a great deal compared to Microsoft’s renting of (more broad and advanced) AI data center capacity from Nebius.

CoreWeave’s all-stock deal to buy Core Scientific was initially valued at ~$9 billion, but with the subsequent decline in its shares, it’s worth about 40% less. And in purchasing Core Scientific, CoreWeave is saving $10 billion in what it would have paid the company to lease data center infrastructure over the next 12 years.

As it stands, Microsoft is getting about 300 megawatts in data center power capacity from Nebius, while Core Scientific boasts that its footprint is in excess of 1,300 megawatts. So, on the surface, it looks like an absolute steal for CoreWeave.

But again, this is not an apples-to-apples comparison; not all access to AI computing infrastructure is created equal.

There are differences in the type of AI infrastructure provided by the two: Nebius owns GPUs, while Core Scientific doesn’t, and what it provides in the software layer isn’t offered by Core Scientific as a stand-alone entity. This is the difference between the “full stack” approach (Nebius) and a “colocation” approach (Core Scientific).

That being said, CoreWeave’s acquisition of Core Scientific, once completed, will make the combined entity’s business model look more like Nebius’ model, which, as Microsoft just told us, is something that top hyperscalers are willing to pay a pretty penny for.

markets

UNH rises after preliminary data shows most Medicare Advantage enrollees will be on more lucrative, top-rated plans

UnitedHealth rose more than 4% in premarket trading on Tuesday after the company disclosed that it expects the majority of its Medicare Advantage enrollees will be on plans rated four stars or higher in 2026.

Though the data is only preliminary, about 78% of UNH’s Medicare Advantage members are in plans rated four stars or higher, the company said in a regulatory filing Tuesday morning. On Monday, the company said it plans to reiterate its full-year guidance when it meets with investors this week.

Insurance companies that provide government-sponsored plans, like Medicare Advantage, have struggled this year amid unexpected rising costs. Plans that are rated four stars or higher earn bonus payments and are typically more lucrative for healthcare insurance providers.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.